Patrick Forde
@patrickforde.bsky.social
Immunotherapy believer. Lung Cancer & Mesothelioma. 🇮🇪 🇺🇸
https://scholar.google.com/citations?hl=en&user=tWgfWfoAAAAJ
https://scholar.google.com/citations?hl=en&user=tWgfWfoAAAAJ
Hopkins crew united!
March 1, 2025 at 1:11 AM
Hopkins crew united!
Now in @JCO_ASCO led by @DrMarkAwad & @MARIANOPROVENCI exploratory arm neoadj ipi nivo for resectable lung cancer in #CM816 w lots of interesting data! Combo neoadj PD1-CTLA4 blockade without chemo likely not a viable strategy for all comers in NSCLC #lcsm ascopubs.org/doi/10.1200/JC…
January 9, 2025 at 8:13 AM
Now in @JCO_ASCO led by @DrMarkAwad & @MARIANOPROVENCI exploratory arm neoadj ipi nivo for resectable lung cancer in #CM816 w lots of interesting data! Combo neoadj PD1-CTLA4 blockade without chemo likely not a viable strategy for all comers in NSCLC #lcsm ascopubs.org/doi/10.1200/JC…
Excellent presentation by Dr. @VirginiaCalvo6 @gecp_org of the recently published Spanish Lung Cancer Group consensus on management of stage III NSCLC. Neoadjuvant chemo-IO has changed the game for this stage of disease. #lcsm
November 21, 2024 at 5:36 PM
Excellent presentation by Dr. @VirginiaCalvo6 @gecp_org of the recently published Spanish Lung Cancer Group consensus on management of stage III NSCLC. Neoadjuvant chemo-IO has changed the game for this stage of disease. #lcsm
Anyone come across this before? It seems this trial recruitment company cold emails oncologists and offers them cash to refer pts to other centers for specific clinical trials, seems ethically v murky and perhaps legally so as well?
November 18, 2024 at 10:31 PM
Anyone come across this before? It seems this trial recruitment company cold emails oncologists and offers them cash to refer pts to other centers for specific clinical trials, seems ethically v murky and perhaps legally so as well?